Melatonin for lupus symptoms
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This study tests whether taking melatonin helps reduce lupus disease activity. It may offer a new way to manage your symptoms with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18 to 60 with a lupus diagnosis.
- Your lupus is currently active but not life-threatening.
- Your lupus medications have been stable for the last three months.
- You must not have other autoimmune diseases, severe organ damage, or uncontrolled health issues.
- You cannot be taking certain medications like sedatives, antidepressants, or blood thinners.
- You must not be pregnant, planning pregnancy, or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at sleep problems in people with lupus and how they might affect your daily life. By filling out questionnaires, you can help researchers find ways to improve sleep for everyone with this condition.
This study tests whether a special type of stem cell treatment (called UC-MSC) can help calm lupus when standard medicines aren't enough. It's for people with active lupus who have tried other non-steroid medications.
This trial tests whether sirolimus, a medication usually used to prevent organ transplant rejection, can help reduce lupus disease activity. If you have active lupus that isn't severe in your kidneys or brain, this could be a new treatment option.
This trial tests a new treatment for people with active lupus who haven't responded well to steroids and at least two other immune-suppressing drugs, including a biologic. It aims to find a better option for controlling lupus symptoms.
This study tests an experimental daily pill (BI 3000202) for people with active lupus (SLE) to see if it can reduce disease activity. It compares different doses against a placebo, and you must already be on stable lupus background treatment.
This study tests a new drug called LBL-047 in healthy people and in people with mild to moderate lupus. It helps check if the drug is safe and how the body processes it. Participating may help find better treatments for lupus.
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.